ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Arch Therapeutics Inc (QB)

Arch Therapeutics Inc (QB) (ARTH)

0.20
0.00
( 0.00% )
Actualizado: 07:18:31

Su centro para precios en tiempo real, ideas y debates en vivo

ARTH Noticias

Solo noticias oficiales

ARTH Discussion

Ver más
zino zino 3 meses hace
DTC Low Floats are the PinkSheet runners lately
👍️0
zino zino 3 meses hace
$ARTH DTC Shares Just 1.37 Million...
https://x.com/gus94202612/status/1840203380335001974
👍️0
moneymaker290 moneymaker290 5 meses hace
Excellent question
👍️0
ANTI-BAGHOLDER ANTI-BAGHOLDER 6 meses hace
What happened to going onto Nasdaq?
👍️0
moneymaker290 moneymaker290 6 meses hace
Anyone know what these filings r for??
👍️0
Snowy_Owl Snowy_Owl 8 meses hace
I'm old enough to remember when an announcement like this excited me.

Arch Therapeutics will present AC5 again at the spring Symposium on Advanced Wound Care on May 14-18. CEO Terry Norchi said: “Prior presentations at SAWC included a case of limb salvage in a 32 year-old patient with a necrotic spider-bite; management of post-Mohs surgery wounds; and treatment of recalcitrant wounds that previously failed to respond to other modalities. Clinicians manage a broad array of acute and chronic challenging wounds, often in patients with concurrent medical problems that interfere with healing.”
👍️0
blackngold63 blackngold63 11 meses hace
The float is over a million shares and only $1,373 worth of stock changed hands today.
Less than the price of one of Norchi's suits. Amazing.
👍️0
moneymaker290 moneymaker290 11 meses hace
Latest report,,,TOTAL REVENUE for 2023 was $45,800 or $3,800 per month. Let me repeat,,total REVENUE, $45,800 for the YEAR....how can this guy, Terry not end up is Prison,,,,how can anyone continue to loan him money...
👍️0
moneymaker290 moneymaker290 11 meses hace
That was the longest report I have ever read...talked 95% about years past...I never did see sales...???
👍️0
moneymaker290 moneymaker290 11 meses hace
Unfortunately, will go towards zero....Terry has made himself a great living for years, by milking this company
👍️0
Snowy_Owl Snowy_Owl 1 año hace
I wonder if December Medicare/Medicaid sales dropped.

If I’m wrong please correct me, if ARTH can’t hold $4 isn’t the up listing off the table?
👍️0
SriMaharaj SriMaharaj 1 año hace
It will continue to go up from here with anticipation of very good news.
👍️0
Long Duk Dong Long Duk Dong 1 año hace
Nice rebound today, still has legs!
👍️0
moneymaker290 moneymaker290 1 año hace
He sees the writing on the wall...this company will be dark soon. I'm sad to say...Poorly run for years, but CEO has made out quite well...
👍️0
Snowy_Owl Snowy_Owl 1 año hace
VP of Sales, Dan Yrigoyen, resigned. He was expensive. The position did not seem to be a good fit.

I have no idea if this influenced the most recent drop in share price.
👍️0
moneymaker290 moneymaker290 1 año hace
This POS is unfortunately showing its true colors..
👍️0
Long Duk Dong Long Duk Dong 1 año hace
SP getting killed today!
👍️0
Snowy_Owl Snowy_Owl 1 año hace
"Once it cross 11 then it will move fast."

It's more important to me how far it will move rather than how fast. Factoring in the most recent 1-for-200 reverse stock split the share price has what I think is an unfeasibly long row to hoe before I'm close to breaking even.
👍️0
SriMaharaj SriMaharaj 1 año hace
Once it cross 11 then it will move fast. We should be hearing soon on moving stock to upper stock exchange soon.
👍️0
SriMaharaj SriMaharaj 1 año hace
Going up. Huge bid. People want to get in before it goes on Nasdaq.
👍️ 1
SriMaharaj SriMaharaj 1 año hace
Wow. 12K+ volume in 5 minutes of opening. Selling done. Time to buy and take it to next high level.
👍️0
SriMaharaj SriMaharaj 1 año hace
It did hold 10 today. This tells me that it will be 20+ tomorrow.
👍️0
JDT72 JDT72 1 año hace
That is my hope for sure, today was wild and hard to hold through that run.
👍️0
SriMaharaj SriMaharaj 1 año hace
They are going on Nasdaq in Jan 2024. This could be the reason they asked for advance. I believe float is locked and going to fly to the moon before goes into Nasdaq.
👍️0
JDT72 JDT72 1 año hace
New to this site, started following ARTH based on Zacks ranking them as a Strong Buy and their top scoring stock for their combined ranking of value/growth/momentum. I am a bit concerned by the history of them and the recent $250K Shareholders Advance taken on 11/29.
👍️0
SriMaharaj SriMaharaj 1 año hace
wow. With only 100K it's going to 100%+. What will happen if this has 500K volume. I believe it will reach $100 with that volume. No shares available.
👍️0
Long Duk Dong Long Duk Dong 1 año hace
Another beauty day for ARTH!
👍️0
TFWG TFWG 1 año hace
Deleted
👍️0
TFWG TFWG 1 año hace
Searching and seaching for one simple answer: WHAT THE HELL IS GOING ONE?????
👍️0
SriMaharaj SriMaharaj 1 año hace
wow, second round has started. It will cross $10 this time.
👍️0
Snowy_Owl Snowy_Owl 1 año hace
I think the Lazarus moment is because ARTH was given an extension until early January 2024 to up list and this may be viewed by some as a positive that will take a future reverse split off the table.

I'm not excited by the current stock price as I think it has some characteristics of a pump 'n dump.
👍️0
blackngold63 blackngold63 1 año hace
Have no idea what is going on. Appears to have risen from the Dead with no news and relatively small volume.
👍️0
abazaba375 abazaba375 1 año hace
Congrats
👍️0
abazaba375 abazaba375 1 año hace
Yep
👍️0
Long Duk Dong Long Duk Dong 1 año hace
No posts on this board for months, the pps explodes in the last weeks..... and.....Silence.
👍️0
Snowy_Owl Snowy_Owl 1 año hace
Anyone else notice the share price has been .666 for some time now? Weird.
👍️0
moneymaker290 moneymaker290 1 año hace
You are Correct..imho
👍️0
blackngold63 blackngold63 1 año hace
This is Norchi's retirement plan.
He has screwed this up so much he knows he can never get another job in the industry so he will milk this as long as he can.
👍️0
moneymaker290 moneymaker290 1 año hace
I am sad to say I've been in the stock for 8 years at least he doesn't know his butt from first base talking about Norchi... he knows how to keep the company afloat so he can get that huge paycheck every month. That's all this is about now
👍️0
Snowy_Owl Snowy_Owl 1 año hace
I'm not qualified to judge the legality of Norchi's actions but I do feel I am qualified to assess this most recent action as blatantly underhanded.

"What Norchi has done and continues to do HAS to be illegal,don't u think"
👍️0
moneymaker290 moneymaker290 1 año hace
What Norchi has done and continues to do HAS to be illegal,,don't u think
👍️0
Snowy_Owl Snowy_Owl 1 año hace
Arch Therapeutics has been pretty much over for me for awhile now. Recent actions have eliminated any remaining doubts I may have had.

ARTH dropped 31% on Thursday 9/7/23 after a series of SEC filings. On September 1 they filed a Form 14C informing us that certain actions were taken by the written consent of the holders of a majority of the outstanding voting stock in lieu of a meeting. They increased the number of authorized shares of stock from 12,000,000 to 350,000,000 shares. Then said the Board can approve another reverse split between 1-for-1.5 and 1-for-20.

On September 6 they filed an 8-K to amend the convertible notes to extend the date of the required up list to NASDAQ from August 31 to September 30. That means another reverse split is imminent because they need a stock price over $4 to up list.

In the future, anytime I get a whiff of a stock contemplating a reverse split I am selling what I own, walking away, and never looking back.
👍️0
moneymaker290 moneymaker290 1 año hace
POS keeps going down. There is no what that a crime has been committed by Norchi...personal cash reagistar
👍️0
moneymaker290 moneymaker290 1 año hace
13G filed today..anyone know who this is for
👍️0
Polyphemus Polyphemus 2 años hace
Currently extending maturity of financing until a new exchange listing (July). $4M market cap for the last decade. Commercial since 2019
👍️0
blackngold63 blackngold63 2 años hace
All things considered, the stock price is actually holding up well.
No money coming in, no prospect of any money coming in, and yet it has been fairly stable.
I was sure it would be down to a buck by now.
👍️0
moneymaker290 moneymaker290 2 años hace
This has always been just a money machine for CEO Terry N...isn't that against the law??
👍️0
Polyphemus Polyphemus 2 años hace
Inventory - 88% of assets; 3-mo revenue of $16K, increase of SG&A of $43K
👍️0
Snowy_Owl Snowy_Owl 2 años hace
10Q will be filed late.

“ PART III — NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Arch Therapeutics, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the period ended March 31, 2023 by the prescribed due date without unreasonable effort or expense because of the circumstances described below.

“The Company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023, cannot be filed within the prescribed time period because the Company requires additional time for compilation and review to insure adequate disclosure of certain information required to be included in the Quarterly Report on Form 10-Q, including the XBRL (eXtensible Business Reporting Language) Interactive Data Files for the financial statements and notes included in the Quarterly Report. The Company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 will be filed on or before the 5th calendar day following the prescribed due date.”
👍️0
Polyphemus Polyphemus 2 años hace
Waiting for revenue numbers instead of conference presentations. Expect to have major inventory write-off in the not so distant future. Exec comp will probably exceed R&D and sales expenses combined.
👍️0

Su Consulta Reciente